References
- Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin, 2002, 52 (1): 23–47.
- Trimble E. L., Karlan B. Y., Lagasse L. D., Hoskins W. J. Diagnosing the correct ovarian cancer syndrome. Obstet Gynaecol, 1991, 78 (6): 1023–6.
- Chen S.S., Lee L. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynaecol Oncol, 1983, 16 (1): 95–100.
- Berek J. S., Hacker N. F. Practical Gynaecologic Oncology, Baltimore, Williams & Wilkins, 1994.
- Orris B. G., Geisler J. P., Geisler H. E. Ovarian carcinoma metastatic to bilateral axillary lymph nodes. A case report. Eur J Gynaecol Oncol, 1999, 20 (3): 189–90.
- Walsh R., Kornguth P. J., Soo M. S., Bentley R., DeLong D. M. Axillary lymph nodes: mammographic, pathologic and clinical correlation. AJR, 1997, 168 (1): 33–38.
- Iglehart J. D. The breast. In: Sabiston D. C. (ed.). Textbook of Surgery. Philadelphia, Saunders, 1991: 529.
- Bjurstam N. The radiographic appearance of normal and metastatic axillary lymph nodes. Recent Results Cancer Res, 1984, 90: 49–54.
- Dvoretsky P. M., Richards K. A., Angel C., Rabinowitz L., Stoler M. H., Beecham J. B., Bonfiglio T. A. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol, 1988, 19 (1): 57–63.
- Sitzenfrey A. Mammakarzinom zwei Jahre nach abdominaler radikal operation wegen doppelseitigen Carcinoma ovarii. Prag Med Wochenschr, 1907, 32: 221–35.
- Sandison A. T. Metastatic tumours in the breast. Br J Surg, 1959, 47: 54–8.
- Kayikcioglu F., Boran N., Ayhan A., Guler N. Inflammatory breast metastases of ovarian cancer: a case report. Gynaecol Oncol, 2001, 83 (3): 613–16.
- Manini C., Pietribiasi F., Sapino A., Donadio S. Serous cystade-nocarcinoma of the ovary with simultaneous breast metastases. Description of a case. Pathologica, 1998, 90 (2): 152–5.
- Kaufmann O., Deidesheimer T., Muehlenberg M., Deicke P., Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology, 1996, 29 (3): 233–40.
- Athanassiadou P., Athanassiades P., Kyrkou K., Lazaris D., Kyragiannis G., Petrakakou E., Michalas S. Immuno-cytochemical determination of EGFR, OV 632 and OC 125 in primary ovarian cancer patients. Oncology, 1995, 52 (2): 145–9.
- Koelma I. A., Nap M., Rodenburg C. J., Fleuren G. J. The value of tumour marker CA 125 in surgical pathology. Histopathology, 1987, 11 (3): 287–94.
- Bast R. C. Jr., Klug T. L., St. John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L., Zurawski V. R. Jr., Knapp R. C. A radio-immuno-assay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med, 1983, 309 (15): 883–7.
- Bast R. C. Jr, Xu F. J., Yu Y. H., Barnhill S., Zhang Z., Mills G. B. CA 125: the past and the future. Int J Biol Markers, 1998, 13 (4): 179–87.